Xanax and Fentanyl: Counterfeit Pills, Overdose and Naloxone

Pharmaceutical Xanax does not contain fentanyl. Xanax is the brand name for alprazolam, a benzodiazepine. Fentanyl becomes part of the Xanax risk picture in two different ways: counterfeit pills sold as Xanax can contain illegally made fentanyl, and a person can also take alprazolam and fentanyl or another opioid during the same period. Both situations can lead to severe central nervous system depression, but the source of exposure matters because it changes what the person may know about the drugs involved.

Current U.S. Xanax labeling carries a boxed warning that combining benzodiazepines with opioids can cause profound sedation, respiratory depression, coma and death. CDC also warns that illegally made fentanyl is pressed into counterfeit pills that resemble alprazolam products. Someone who believes they took only a Xanax-type pill can therefore develop an opioid overdose without expecting opioid effects.

If a person cannot be awakened, is breathing slowly or irregularly, has blue or gray lips or skin, or has collapsed after taking a pill, treat the situation as a possible overdose. Give naloxone if it is available and call emergency services. Naloxone can reverse fentanyl and other opioid effects, but it does not reverse alprazolam itself.

Xanax and Fentanyl at a Glance

Why Fentanyl Is Found in Pills Sold as Xanax

Counterfeit prescription pills are manufactured outside the regulated pharmaceutical supply. They can be pressed to resemble commonly recognized medications and sold under familiar names even when their chemical contents are different.

CDC identifies counterfeit pills resembling alprazolam among the forms in which illegally made fentanyl is sold. FDA states that counterfeit medicines can contain the wrong active ingredient, too much or too little of an ingredient, no expected active ingredient or other harmful ingredients. DEA also lists Xanax among the prescription products commonly imitated by counterfeit-pill manufacturers.

This creates a specific problem for people seeking benzodiazepines. Someone may expect the sedation or anxiety relief associated with alprazolam but instead receive fentanyl, an illicit benzodiazepine, a different sedative, an unpredictable alprazolam amount or a combination of substances.

The counterfeit market is not chemically uniform. CDC surveillance has found both illegally manufactured fentanyls and illicit benzodiazepines in deaths involving counterfeit pills. That is why a fixed statement such as every fake Xanax contains fentanyl is inaccurate. The risk is that an unregulated pill can contain fentanyl and that the person taking it cannot reliably determine the contents from the product name or appearance.

The Fake Xanax guide covers counterfeit-pill identification and composition in greater depth.

Pharmaceutical Xanax vs Counterfeit Xanax

Legitimate Xanax is a regulated alprazolam product. The branded U.S. product and approved generic alprazolam products have standardized labeling, defined strengths and regulated manufacturing. Medication dispensed by a licensed pharmacy through the legitimate supply chain provides traceability that an informal pill purchase does not.

A counterfeit Xanax tablet is made to imitate a pharmaceutical product. It may copy a bar shape, color, score pattern, imprint or packaging. A convincing visual match cannot establish authenticity because the physical design can be reproduced with illicit pill presses and dies.

Source information therefore matters more than appearance. A tablet found loose, bought from a dealer, obtained through an unverified website or sold informally as a Xanax bar lacks the same product assurance as medication dispensed through a regulated pharmacy.

This distinction also affects clinical history. A person may accurately report taking one bar or one Xanax and still be unable to provide a verified alprazolam dose. When the product is unregulated, tablet count and street name should be documented as reported information rather than converted automatically into a pharmaceutical dose.

What Happens When Xanax and Fentanyl Are Taken Together?

Alprazolam and fentanyl depress the central nervous system through different receptor systems. Alprazolam enhances inhibitory signaling through GABA-A receptors. Fentanyl activates mu-opioid receptors and can suppress the brainstem drive to breathe.

When benzodiazepine and opioid effects overlap, sedation can deepen while respiratory function worsens. Current Xanax labeling warns that concomitant benzodiazepine and opioid use can result in profound sedation, respiratory depression, coma and death. The warning applies to known co-use of prescribed medications as well as to situations in which an opioid is encountered unexpectedly.

A person may become very sleepy, confused, poorly coordinated or difficult to awaken. Fentanyl adds the possibility that breathing becomes slow, shallow, irregular or absent. The combination can also make it harder for witnesses to recognize what is happening because severe opioid toxicity can initially look like unusually deep sleep.

Prescribed co-use also requires caution. A patient who receives an opioid and alprazolam from clinicians has a known medication history, but the pharmacologic risk remains. The FDA boxed warning advises clinicians to reserve combined use for situations in which alternatives are inadequate, limit dose and duration to what is required and monitor for sedation and respiratory depression.

How a Fentanyl-Related Overdose Can Look After a Supposed Xanax Pill

The most urgent signs are related to consciousness and breathing. A person may be at risk of opioid overdose when they are difficult or impossible to wake, breathing very slowly, breathing irregularly or no longer breathing normally.

• Unable to awaken normally
• Very slow, shallow or irregular breathing
• Stopped breathing
• Blue, gray or unusually pale lips, fingertips or skin
• Pinpoint pupils, although pupil size alone should not determine the response
• Limp body or collapse
• Snoring, choking or gurgling sounds in an unresponsive person
• Loss of consciousness

Alprazolam intoxication can also cause marked drowsiness, impaired coordination, slurred speech, memory impairment and reduced alertness. The presence of benzodiazepine effects does not rule out fentanyl. A counterfeit pill can contain more than one depressant and produce a mixed clinical picture.

During an emergency, the pill’s claimed name is less important than the person’s breathing and responsiveness. A witness should not assume that an unresponsive person is simply sleeping off Xanax when breathing is abnormal.

What to Do if Fentanyl Exposure Is Suspected

If someone may be experiencing an opioid overdose, call emergency services and give naloxone if it is available. CDC advises administering naloxone when opioid overdose is suspected because it can rapidly reverse opioid effects and restore breathing.

More than one dose can be necessary in some fentanyl overdoses. Continue following emergency instructions and stay with the person until help arrives. If normal breathing does not return after the first dose, additional naloxone may be given according to the product directions and emergency guidance.

Emergency evaluation remains important even when the person wakes up. The opioid effect can recur, another sedative may still be active, and complications such as aspiration, injury or prolonged oxygen deprivation can require treatment.

A response to naloxone after a pill sold as Xanax raises concern that an opioid was part of the exposure. It does not identify the exact substance or prove that fentanyl was the opioid involved. Toxicology, scene information, product testing and the full clinical history may be needed to clarify the exposure.

Will Naloxone Reverse Xanax?

Naloxone does not reverse alprazolam because alprazolam is a benzodiazepine rather than an opioid. Naloxone works by blocking opioid receptors.

If fentanyl or another opioid is present, naloxone can reverse the opioid component of the overdose. Breathing may improve while benzodiazepine-related sleepiness, confusion, amnesia or poor coordination continues.

This partial improvement is important to recognize. A person can remain significantly sedated after the opioid effect has been reversed, especially when alprazolam, alcohol or another depressant was also taken.

Naloxone should not be withheld because the drug exposure is uncertain. CDC notes that naloxone will not harm a person who is overdosing on a non-opioid drug, while it can be lifesaving when an opioid is involved.

Can You Tell if a Xanax Pill Contains Fentanyl by Looking at It?

Appearance cannot reliably determine whether a pill contains fentanyl. Counterfeit tablets can imitate legitimate prescription products closely enough that shape, color, score lines and imprint are not dependable authentication methods.

Obvious defects can raise suspicion, but the absence of defects does not establish that a pill came from a pharmaceutical manufacturer. A well-made counterfeit may reproduce the same familiar design that people use to identify a Xanax bar.

The same problem applies to packaging. Counterfeit packaging can be copied, and loose tablets may have no traceable packaging at all. A legitimate dispensing record and regulated pharmacy source provide more meaningful assurance than a photograph or imprint comparison alone.

This is also why the terms bar, football, Hulk, School Bus or other Xanax slang cannot establish chemical contents. Street language can describe what a pill is believed to be, what it looks like or how it is marketed without verifying what is inside it.

Can Fentanyl Test Strips Prove a Pill Is Real Xanax?

Fentanyl test strips can provide information about whether fentanyl is detected in a drug sample, but they do not authenticate a pill as pharmaceutical Xanax. A negative fentanyl result does not establish that the tablet contains the expected amount of alprazolam or that it came from a regulated manufacturer.

A counterfeit pill can contain another benzodiazepine, another sedative, methamphetamine, an unexpected alprazolam amount or a different substance while testing negative for fentanyl. Consumer-level testing therefore answers a narrower question than pharmaceutical identification.

More advanced laboratory analysis can identify a wider range of compounds, but results still apply to the tested sample. Illicit manufacturing does not guarantee that every tablet in a batch has the same composition or concentration.

For treatment assessment, testing is most useful when considered alongside the source of the pills, overdose history, symptoms, naloxone response, toxicology and the person’s reported pattern of use.

Why One Counterfeit Xanax Can Affect Someone Differently From Another

Regulated pharmaceutical manufacturing is designed to produce consistent medication strength and composition. Illicit pill production does not provide the same quality control.

Two tablets that look alike can contain different active drugs or different amounts of the same drug. Even pills from the same purchase can be inconsistent if ingredients were mixed unevenly or tablets came from different production batches.

This unpredictability can explain reports in which a person previously used pills sold as Xanax without an opioid-type reaction and then later experienced severe respiratory depression from a similar-looking pill. Prior experience with a seller, imprint, color or batch cannot confirm the contents of a later tablet.

CDC’s counterfeit-pill surveillance also shows that the illicit market varies by region and over time. National data should therefore be used to describe the existence and seriousness of the risk rather than to assign a fixed probability to one individual pill.

Repeated Counterfeit Xanax Use Can Create More Than One Dependence Problem

A person repeatedly using pills sold as Xanax may develop physical dependence on alprazolam or another benzodiazepine if that is what the supply contains. If fentanyl or another opioid is repeatedly present, opioid exposure can occur at the same time.

The clinical history can become difficult to interpret when the person does not know the exact contents. Symptoms between doses may reflect benzodiazepine withdrawal, opioid withdrawal, anxiety, sleep disruption or a combination of these problems.

Overdose history also matters. Episodes of unusually deep sedation, slow breathing, naloxone administration or unexpected opioid-positive toxicology can indicate that a counterfeit supply has introduced opioids into what the person believed was benzodiazepine use.

Treatment assessment should therefore ask about both benzodiazepine and opioid exposure rather than assuming that a person seeking help for street Xanax has only one drug problem.

Why Xanax Withdrawal Still Matters After Counterfeit-Pill Use

Regular alprazolam exposure can produce physical dependence. Current Xanax labeling warns that abrupt discontinuation or rapid dose reduction after continued use can cause acute withdrawal reactions that may be life-threatening.

Withdrawal can include anxiety, insomnia, agitation, tremor and other symptoms, with seizures and delirium among the more serious complications of benzodiazepine withdrawal. The 2025 Joint Clinical Practice Guideline on Benzodiazepine Tapering advises against abruptly discontinuing benzodiazepines in people who are likely to be physically dependent.

A universal internet taper is inappropriate because the actual exposure may be uncertain and patient factors differ. A clinician may need to consider duration and frequency of use, known or estimated dose, prior withdrawal, seizure history, co-occurring alcohol or opioid use, medical conditions and psychiatric symptoms.

The Xanax Withdrawal resource covers withdrawal symptoms and clinical management in more detail.

How Xanax and Fentanyl Exposure Changes Treatment Planning

Repeated use of counterfeit Xanax can require a broader assessment than treatment for a single known substance. The first task is to establish what can be known about benzodiazepine exposure, opioid exposure, overdose history and withdrawal risk.

A person may have benzodiazepine physical dependence, benzodiazepine use disorder, opioid use disorder, both disorders or neither. Unexpected fentanyl exposure after occasional counterfeit-pill use does not automatically establish opioid use disorder. Repeated opioid use, craving, loss of control, continued use despite harm and other clinical criteria have to be assessed separately.

Likewise, physical dependence on alprazolam does not by itself establish Xanax addiction. Dependence can develop during prescribed treatment. Addiction assessment focuses on the pattern of use and its consequences.

For someone with a history of overdose, treatment planning should include the circumstances of each event: what the pill was believed to be, where it came from, whether breathing slowed, whether naloxone was used, whether emergency care was required and what toxicology showed.

Underlying anxiety, panic symptoms, insomnia or trauma-related symptoms may also influence continued pursuit of benzodiazepines. Treatment is more durable when those conditions are assessed alongside the substance-use pattern rather than left untreated after the pills are removed.

When Medical Detox or Residential Treatment May Be Considered

Many people taking prescribed benzodiazepines can be managed in outpatient care, but higher-risk withdrawal or polysubstance use can require a more intensive setting. The 2025 ASAM-led benzodiazepine guideline recommends inpatient or medically managed residential care for severe or complicated benzodiazepine withdrawal, including situations requiring close monitoring and seizure-risk management.

A medically supervised detox program may be appropriate when there is significant benzodiazepine dependence, prior withdrawal seizures, severe withdrawal symptoms, unstable medical or psychiatric conditions, heavy use of multiple depressants or uncertainty about repeated fentanyl exposure.

Residential treatment can provide a structured setting after acute stabilization when repeated counterfeit-pill purchasing, cravings, polysubstance use, unstable living conditions or repeated relapse make outpatient care difficult to sustain.

Dual diagnosis treatment becomes especially relevant when panic disorder, generalized anxiety, depression, trauma symptoms or another psychiatric condition is closely tied to the person’s benzodiazepine use.

Related Xanax resources include Xanax Addiction and Xanax Overdose.

Frequently Asked Questions About Xanax and Fentanyl

Does real Xanax contain fentanyl?

No. Pharmaceutical Xanax contains alprazolam. Fentanyl risk is associated with counterfeit pills sold as Xanax or with separate fentanyl or opioid use.

Can fake Xanax contain fentanyl?

Yes. CDC, DEA and SAMHSA all warn that counterfeit pills made to resemble alprazolam products can contain illegally made fentanyl. The contents of one counterfeit pill cannot be assumed from its appearance.

Can Xanax and fentanyl cause an overdose together?

Yes. Alprazolam and fentanyl are both central nervous system depressants. Current Xanax labeling warns that benzodiazepines combined with opioids can cause profound sedation, respiratory depression, coma and death.

Will naloxone work on fentanyl in fake Xanax?

Naloxone can reverse the opioid effects of fentanyl. It does not reverse alprazolam, so sedation from a benzodiazepine or another non-opioid depressant can remain after breathing improves.

What does fentanyl-laced Xanax look like?

There is no dependable visual appearance. Counterfeit tablets can copy familiar Xanax shapes, colors, score lines and imprints closely enough that appearance alone cannot establish contents.

Can you smell or taste fentanyl in a Xanax pill?

Smell and taste are not reliable ways to identify fentanyl in an unregulated pill. Product source and chemical testing provide more useful information than sensory inspection.

Does a negative fentanyl test mean the pill is real Xanax?

No. A negative fentanyl result does not authenticate the pill, confirm an alprazolam dose or rule out other unexpected substances.

Can someone have both benzodiazepine and opioid dependence from counterfeit Xanax?

It is possible if repeated pills contain both drug classes or if the person also uses opioids separately. Treatment assessment should evaluate benzodiazepine withdrawal risk and opioid exposure independently.

Should someone stop Xanax suddenly after a fentanyl scare?

Someone who may be physically dependent on alprazolam should not abruptly stop a regular benzodiazepine regimen without clinical guidance. Rapid discontinuation can cause severe withdrawal, including seizures in some cases.

Sources

• DailyMed: Xanax (alprazolam) Prescribing Information: current boxed warning for concomitant opioid use, respiratory depression, abuse, dependence and withdrawal.
• FDA: Counterfeit Medicine: counterfeit medicines can contain incorrect, missing or harmful ingredients and are linked to fentanyl-related overdose risk.
• CDC: Fentanyl: illegally made fentanyl, counterfeit pills resembling alprazolam and opioid overdose risk.
• CDC MMWR: Drug Overdose Deaths With Evidence of Counterfeit Pill Use: U.S. surveillance of counterfeit oxycodone and alprazolam evidence, illicit fentanyls and illicit benzodiazepines.
• CDC: Lifesaving Naloxone: naloxone response, breathing restoration and the possibility that additional doses may be required.
• SAMHSA: Misuse of Prescription Drugs, Opioids and Fake Pills: counterfeit pills made to resemble Xanax and other prescription drugs.
• DEA: Fake Prescription Pills: counterfeit pills made to resemble alprazolam and other prescription medications.
• ASAM: Joint Clinical Practice Guideline on Benzodiazepine Tapering: current benzodiazepine withdrawal, co-prescribed opioid risk and level-of-care guidance.